Therefore, S100A9 may initiate and amplify neutrophilic inflammation in patients with uncontrolled, severe asthma and could be used as a biomarker of neutrophilic inflammation in this group of patients [118,119,120]. The gene discussed is S100A9; the disease is asthma.